Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.

@article{Lerner1992EtoposideDA,
  title={Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.},
  author={Adam B. Lerner and Ren{\'e} Gonin and Glenn D. Steele and Robert J. Mayer},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1992},
  volume={10 4},
  pages={536-40}
}
PURPOSE A phase II study of etoposide, doxorubicin, and cisplatin (EAP) therapy in patients with advanced gastric carcinoma was performed in an attempt to confirm encouraging results reported by German investigators using an identical EAP regimen. PATIENTS AND METHODS Thirty-six consecutive, previously untreated patients with surgically unresectable, measurable gastric carcinoma were treated every 28 days with etoposide (120 mg/m2, days 4, 5, and 6), doxorubicin (20 mg/m2, days 1 and 7), and… CONTINUE READING